Amyloid-beta protein — the primary constituent of the plaques found in the brains of Alzheimer’s disease patients — may be part of the body’s first-line system to defend against infection. In a new study, researchers describe evidence that amyloid-beta protein is an antimicrobial peptide, part of the innate immune system.